From Ideas to Actions: A Public-Data Decision-Support Toolchain Across the Venture Lifecycle
cs.AI
Quick verdict
Claims an auditable public-data founder-decision toolchain (F0.5 0.54 clean validation); transparent, but scale validation incomplete, Part Two exploratory.
Summary
The paper presents a two-part decision-support toolchain built exclusively from free public data for startup founders. Part One converts a proposal into a structured five-dimension candidate card, runs time-bounded market (TAM/SAM/SOM with Porter discounts) and moat (VRIO) checks against web evidence, and aggregates verdicts with a deterministic 0.5M+0.5U rule. On a 37,569-company AI-adjacent cohort derived from a free Crunchbase snapshot (4.09% SUCCESS), the frozen pipeline achieves F0.5 = 0.5357 [0.412, 0.655] on a row-disjoint 198-company validation sample and 0.6301 pooled over 396 rows, versus 0.2734 for a paired Raw LLM baseline (paired difference +0.357, p < 0.00002); a scale run on 4,000 newly drawn companies is incomplete (1,027 cases, post-stratified F0.5 0.6506). A 29-vendor AI-inference case study adds conditional market-entry guidance. Part Two reconstructs provenance-bearing investor-company event chains from SEC filings, portfolio pages, and news; on a 501-company evaluable chip subset it registers 23,308 label-blind patterns, of which only P8 survives all robustness checks, and finds funding participation makes up 79% of 195 confirmed post-investment rows. Main limitations: outcome labels proxy funding/exit milestones, benchmark prevalence (24.2%) diverges from the cohort, public observability is outcome-selective, and all findings are retrospective associations rather than causal effects.
Review complete
Assessment at a glance
6
risk flags identified
● high 0
● medium 4
● low 2
5 strengths · 5 weaknesses · 5 author questions
AI text signal = Binoculars zero-shot detector score over 20 sampled passages (Fast-DetectGPT co-reported) — absence does not prove human authorship, and a flag does not imply misconduct.
Levels reflect verification complexity — not a quality score. Evolve never rates your paper.
Key claims under review
- A frozen public-data pipeline (candidate card + time-bounded M/U checks + deterministic 0.5M+0.5U aggregation) achieves F0.5 = 0.5357 on a row-disjoint 198-company validation sample and 0.6301 pooled on 396 rows, versus 0.2734 for a paired Raw LLM baseline.
- Post-stratified estimates from 1,027 completed cases of a separately drawn 4,000-company scale cohort (0.6506 [0.598, 0.707]) are consistent with the benchmark, but the incomplete run precludes a deployment-grade generalization claim.
- In the chip-company study, sustained product, customer, and supply-chain progress is associated with higher observed SUCCESS shares (+15.6 pp for P3), while financing participation alone does not establish operating progress.
- Funding participation constitutes 79% of 195 confirmed publicly visible post-investment actions, and the evidence tentatively favors matching investor type to founder objective (acquisition-oriented founders to corporate investors with acquisition histories; independence-oriented founders to financing-led VCs).
- All results are explicitly observational associations, not causal effects, investor rankings, or investment advice.
Strengths
Rare transparency about evidence boundaries
Sections 5.6/11.1 and Table 8 self-report the incomplete scale run (1,027 of 4,000 cases), differential observability (Fig 13: 69% of SUCCESS vs 25% of FAILURE companies have evaluable chains), the ~$2,560 cost-deferred completion, and even a post-release self-link attribution defect in <1% of event records — before any reviewer finds them.
Evaluation hygiene above the LLM-paper norm
A 198-row threshold-tuning draw is separated from a row-disjoint 198-row validation draw; the pooled 0.6301 is explicitly not presented as untouched-test; leakage removal is audited at 0.36% over-detection and 5.7% under-detection (Section 5.2); Table 2 cleanly separates all validation views.
Statistically well-supported system-level contrast
Honest negative results and a fully exposed decision rule
Concrete reproducibility artifacts for Part Two
Weaknesses
Deployment validity remains open
Outcome construct and prevalence mismatch
Pattern registry labeled on unadjusted tests
Residual point-in-time leakage cannot be excluded
Under-specified evaluation configuration and confounded ablation
Full Review Report
$1.99 · one-timeUnlock the complete preliminary analysis Evolve produced for this paper.
Report preview
Scope & Claims
This single-author paper (arXiv 2609.15219, cs.AI) bundles two systems under one evidence discipline. Part One (Sections 4-6) is a pre-founding proposal evaluator: a five-dimension candidate card, a time-bounded market check (TAM/SAM/SOM with Porter five-forces discounts), a VRIO moat check, and a deterministic 0.5M+0.5U aggregator with a fixed PASS threshold; Figure 3 exposes the complete 3x3 decision surface. Part Two (Sections 7-10) reconstructs provenance-bearing investor-company event chains from free sources (SEC Form D/13D/13G, S-1s, portfolio pages, news) and mines them for retrospective outcome associations. The claims are deliberately modest: feasibility and auditable method — not causal effects, not deployment-grade prediction, not investment advice (Sections 1, 11).
The remaining sections cover Methodology Assessment, Statistical Evidence, Results & Reproducibility, Limitations & Risks, and Verdict & Recommendations.
- All 5 strengths & 5 weaknesses, analyzed in detail
- 6 risk flags with severity, section & reviewer questions
- Methods & statistical evidence assessment
- 5 questions a peer reviewer would ask
- Full six-dimension evaluation report & recommendations
One-time purchase · this paper only
One-time purchase, this paper only. AI-generated preliminary analysis — not peer review.
Frequently asked questions
What F0.5 score does the startup-idea evaluation pipeline achieve?
On a row-disjoint validation sample of 198 companies it scores F0.5 = 0.5357 (95% CI 0.412-0.655); pooled over the 396-row development-plus-validation benchmark it reaches 0.6301, versus 0.2734 for a directly comparable raw-LLM baseline. These are not deployment estimates: the benchmark over-samples successes (24.2% vs 4.09% in the source cohort).
Is the paper's data and code available?
Partially. The Part Two event tables ship as the EventChain dataset on Hugging Face under CC-BY-4.0, with a script that reproduces the 501-company cohort and the P2/P3/P8 pattern counts; the workflows are MIT-licensed skills. Part One releases only aggregate benchmark statistics because its row-level cards derive from a Crunchbase mirror, so those numbers cannot be recomputed without re-running the pipeline yourself.
Does the paper prove which investor types make startups successful?
No. It reports retrospective, announcement-visible associations within one chip-company cohort: 79% of confirmed post-investment actions are further funding, and the guidance is conditional and non-causal — acquisition-oriented founders might examine corporate investors with acquisition histories, while independence-oriented founders might look at financing-led VCs. The paper explicitly states it neither ranks investors nor constitutes investment advice.
What are the main caveats of this study?
Four stand out: the outcome label is a funding/exit proxy rather than profitability or survival; the large-scale validation run is only ~26% complete (1,027 of 4,000 cases); public sources cover successful companies' histories far better than failures' (69% vs 25% evaluable chains); and the 23,308-pattern registry uses unadjusted significance tests, with only pattern P8 surviving every robustness check.
About this review
This is an AI-generated preliminary review by Evolve.Pub, produced from the openly available text of the paper. It is not peer review and does not represent the authors' views. The canonical record of the paper is at the publisher link above.
- Figures 1-18 were analyzed from embedded captions and in-text numbers only; visual encodings (e.g., the Fig 10 strategic-map placement) could not be independently verified.
- Some values appear only inside figure-embedded text (e.g., Fig 15 survival counts), so minor transcription risk cannot be excluded.
- Review is based on arXiv v1; no external peer-review record was available at review time.
Go deeper on this paper
Wrote a paper? Stress-test it before reviewers do.
Upload your manuscript for the same structured scrutiny — reasoning, statistics, evidence, figures, and reproducibility.